| Literature DB >> 33531485 |
Yang Liu1, Shuai He1,2,3, Xi-Liang Wang4, Wan Peng1, Qiu-Yan Chen1, Dong-Mei Chi1,5, Jie-Rong Chen1,6, Bo-Wei Han1, Guo-Wang Lin1,7, Yi-Qi Li1, Qian-Yu Wang1, Rou-Jun Peng1, Pan-Pan Wei1, Xiang Guo1, Bo Li8,9, Xiaojun Xia1, Hai-Qiang Mai1, Xue-Da Hu4, Zemin Zhang10,11, Yi-Xin Zeng12, Jin-Xin Bei13,14,15.
Abstract
The heterogeneous nature of tumour microenvironment (TME) underlying diverse treatment responses remains unclear in nasopharyngeal carcinoma (NPC). Here, we profile 176,447 cells from 10 NPC tumour-blood pairs, using single-cell transcriptome coupled with T cell receptor sequencing. Our analyses reveal 53 cell subtypes, including tumour-infiltrating CD8+ T, regulatory T (Treg), and dendritic cells (DCs), as well as malignant cells with different Epstein-Barr virus infection status. Trajectory analyses reveal exhausted CD8+ T and immune-suppressive TNFRSF4+ Treg cells in tumours might derive from peripheral CX3CR1+CD8+ T and naïve Treg cells, respectively. Moreover, we identify immune-regulatory and tolerogenic LAMP3+ DCs. Noteworthily, we observe intensive inter-cell interactions among LAMP3+ DCs, Treg, exhausted CD8+ T, and malignant cells, suggesting potential cross-talks to foster an immune-suppressive niche for the TME. Collectively, our study uncovers the heterogeneity and interacting molecules of the TME in NPC at single-cell resolution, which provide insights into the mechanisms underlying NPC progression and the development of precise therapies for NPC.Entities:
Year: 2021 PMID: 33531485 DOI: 10.1038/s41467-021-21043-4
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919